VeChain Outshines IBM in Pharma Traceability, Academic Report Highlights Real-Time Anti-Counterfeit Tracking

Sean Williams
VeChain (VET)

Key Takeaways:

  • VeChain has been highlighted in a UNDP-supported report for its superior IoT and blockchain integration in pharmaceutical supply chains.
  • Its ToolChain platform outperformed IBM and Hyperledger in real-time anti-counterfeiting applications.
  • VET continues to show steady growth, backed by over 40 enterprise use cases across multiple industries.

VeChain (VET), a smart contract-compatible blockchain known for supply chain innovation, has been spotlighted in an academic report for its advanced IoT-based tracking and anti-counterfeiting capabilities in the pharmaceutical industry. The report, endorsed by the United Nations Development Program (UNDP), highlights VeChain’s ToolChain as outperforming major enterprise competitors like IBM and Hyperledger.

FairChain Report Emphasizes Need for Transparency in Drug Development

The report titled “FairChain: A Trusted and Transparent Blockchain-Based Ecosystem for Drug Development for Nagoya Protocol Implementation” addresses the growing concern over counterfeit drugs. Following the COVID-19 pandemic, pharmaceutical supply chains came under immense pressure, exposing gaps in tracking and legal oversight for genetic resources used in drug production.

To combat these issues, the FairChain framework was introduced as a blockchain-powered solution that enhances transparency throughout the Drug Development Life Cycle (DDLC). The report specifically identifies VeChain’s infrastructure as particularly well-suited to meet these demands through decentralized, immutable, and transparent data management.

VeChain ToolChain Outperforms IBM and Hyperledger

According to a summary shared by VeChain ambassador Sebastian, the report credits VeChain’s ToolChain with superior performance in real-time pharmaceutical tracking. The platform integrates IoT sensors to offer end-to-end verification and anti-counterfeiting mechanisms—something even large-scale enterprise solutions like IBM and Hyperledger struggle to match in agility and affordability.

This isn’t VeChain’s first recognition in the medical field. In 2017, the Shanghai Municipal Commission of Commerce supported VeChain’s traceability solution as part of an initiative to uphold vaccine quality, making it the only blockchain project officially endorsed by the Shanghai government at the time.

VET Powers Real-World Use Cases Beyond Healthcare

Beyond pharmaceuticals, VeChainThor continues to expand into sectors such as agriculture, automobile manufacturing, and wine traceability. Its blockchain infrastructure powers over 40 enterprise use cases globally, reflecting its maturity and real-world adoption.

Also Read: VeChain Expands VeBetter with BYB Fitness App, Launching at UFC 317 in Las Vegas

Sebastian, a key community figure, emphasized that VeChain is “not a hype coin” but a research-backed, enterprise-ready protocol built for scalable and long-term application.

Market Snapshot: VET Price and Performance

As of writing, VeChain’s native token, VET, is trading at $0.021. The asset has recorded a 0.7% gain in the last 24 hours and is up 7.8% over the past week, reflecting positive sentiment amid growing recognition of its technology.

Disclaimer: The information in this article is for general purposes only and does not constitute financial advice. The author’s views are personal and may not reflect the views of Chain Affairs. Before making any investment decisions, you should always conduct your own research. Chain Affairs is not responsible for any financial losses.

Related Posts